Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian HD Subjects With SHPT
Conditions: Secondary Hyperparathyroidism; Chronic Kidney Disease Interventions: Drug: Etelcalcetide; Drug: Cinacalcet Sponsor: Amgen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 3, 2017 Category: Research Source Type: clinical trials
